Observational studyInternational journal of clinical pharmacy2016

Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer.

Moisés Uriarte-Pinto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.